Showing results (151-160 of 172) with videos related to
Sort By:
Pageof 18
Urology Journal|April 8, 2019
Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder CancerMakito Miyake, Takuya Owari, Mitsuru Tomizawa, et al.Cancers|February 24, 2024
Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint InhibitorsTakuto Shimizu, Makito Miyake, Nobutaka Nishimura, et al.Cancer Science|August 25, 2017
Diagnostic and prognostic role of urinary collagens in primary human bladder cancerMakito Miyake, Yosuke Morizawa, Shunta Hori, et al.Bladder Cancer (Amsterdam, Netherlands)|March 24, 2025
Platinum-based chemotherapy rechallenge or enfortumab vedotin after maintenance avelumab or pembrolizumab for locally advanced or metastatic urothelial carcinomaNobutaka Nishimura, Makito Miyake, Norimi Takamatsu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 13, 2017
Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapyMakito Miyake, Takuya Owari, Takashi Iwamoto, et al.Journal of Endourology|October 16, 2025
Clinical Utility of Ureteral Optical Coherence Tomography for T Staging of Ureteral Cancer: NOCTURN StudyMakito Miyake, Takuto Shimizu, Nobutaka Nishimura, et al.International Journal of Molecular Sciences|October 20, 2017
Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese CohortMakito Miyake, Yoshihiro Tatsumi, Daisuke Gotoh, et al.Japanese Journal of Clinical Oncology|December 9, 2022
Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter studyMakito Miyake, Takuto Shimizu, Yuki Oda, et al.World Journal of Surgical Oncology|February 20, 2019
The diagnostic utility of retroperitoneoscopic tissue biopsy for unresectable retroperitoneal lesions excluding urogenital cancersMakito Miyake, Shinji Fukui, Daisuke Gotoh, et al.Diagnostics (Basel, Switzerland)|January 24, 2020
Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the BladderYoshitaka Itami, Makito Miyake, Sayuri Ohnishi, et al.Pageof 18